Related references
Note: Only part of the references are listed.Characterization of a clinical Clostridioides difficile isolate with markedly reduced fidaxomicin susceptibility and a V1143D mutation in rpoB
Julian Schwanbeck et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Genome-Wide Screening for Enteric Colonization Factors in Carbapenem-Resistant ST258 Klebsiella pneumoniae
Hea-Jin Jung et al.
MBIO (2019)
Discovery and development of DNA polymerase IIIC inhibitors to treat Gram-positive infections
Wei-Chu Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald et al.
CLINICAL INFECTIOUS DISEASES (2018)
Multicentre derivation and validation of a simple predictive index for healthcare-associated Clostridium difficile infection
M. L. Davis et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Temporal development of the gut microbiome in early childhood from the TEDDY study
Christopher J. Stewart et al.
NATURE (2018)
Changes in Prevalence of Health Care-Associated Infections in US Hospitals
S. S. Magill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Short- and long-term effects of oral vancomycin on the human intestinal microbiota
Sandrine Isaac et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing
Zhong Peng et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection
Vanessa W. Stevens et al.
JAMA INTERNAL MEDICINE (2017)
Genomics of the Genus Bifidobacterium Reveals Species-Specific Adaptation to the Glycan-Rich Gut Environment
Christian Milani et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2016)
Burden of Clostridium difficile Infection in the United States
Fernanda C. Lessa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Role of the Intestinal Microbiota in Resistance to Colonization by Clostridium difficile
Robert A. Britton et al.
GASTROENTEROLOGY (2014)
Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
Thomas J. Louie et al.
CLINICAL INFECTIOUS DISEASES (2012)
Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota
S Bartosch et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2004)
Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces
T Matsuki et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2002)
A PCR assay to discriminate human and ruminant feces on the basis of host differences in Bacteroides-Prevotella genes encoding 16S rRNA
AE Bernhard et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2000)
Share Paper
